Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare
Zevra Therapeutics, Inc. Long Term Debt 2013–2025
Zevra Therapeutics, Inc. annual/quarterly long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Zevra Therapeutics, Inc. long term debt for the quarter ending December 31, 2025 were 61.9M, a 4.07% increase year-over-year.
- Zevra Therapeutics, Inc. long term debt for 2025 were 61.9M, a 4.07% increase from 2024.
- Zevra Therapeutics, Inc. long term debt for 2024 were 59.5M, a 1074.58% increase from 2023.
- Zevra Therapeutics, Inc. long term debt for 2023 were 5.1M, a 92.51% decrease from 2020.
- Zevra Therapeutics, Inc. long term debt for 2020 were 67.7M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Zevra Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $62 |
| 2024 | $60 |
| 2023 | $5 |
| 2020 | $68 |
| 2019 | $77 |
| 2018 | $81 |
| Zevra Therapeutics, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $62 |
| 2024-12-31 | $60 |
| 2023-12-31 | $5 |
| 2020-12-31 | $68 |
| 2019-12-31 | $77 |
| 2018-12-31 | $81 |
Zevra Therapeutics, Inc. Long Term Debt — FAQ
Zevra Therapeutics, Inc. (ZVRA) long term debt over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZVRA's long term debt history?
The chart and table above show Zevra Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.